id	sid	eid	entity	type
ajlm-2895	1	1	d. kaboré	PERSON
ajlm-2895	1	2	sourô sanou university teaching hospital	ORG
ajlm-2895	1	3	burkina faso burkina	ORG
ajlm-2895	1	4	burkina faso	ORG
ajlm-2895	1	5	nazi boni university	ORG
ajlm-2895	1	6	burkina faso	ORG
ajlm-2895	1	7	institute of health sciences	ORG
ajlm-2895	1	8	nazi boni university	ORG
ajlm-2895	1	9	burkina	GPE
ajlm-2895	1	10	faso	GPE
ajlm-2895	1	11	j. gonfouli laboratory	ORG
ajlm-2895	1	12	nazi boni university	ORG
ajlm-2895	1	13	burkina faso merci muhigwa laboratory	ORG
ajlm-2895	1	14	nazi boni university	ORG
ajlm-2895	1	15	burkina	GPE
ajlm-2895	1	16	faso	GPE
ajlm-2895	1	17	west african health organization	ORG
ajlm-2895	1	18	burkina faso fernand michodigni	ORG
ajlm-2895	1	19	nazi boni university	ORG
ajlm-2895	1	20	burkina	GPE
ajlm-2895	1	21	faso	GPE
ajlm-2895	1	22	nazi boni university	ORG
ajlm-2895	1	23	burkina	GPE
ajlm-2895	1	24	faso	GPE
ajlm-2895	1	25	jacques zoungrana	PERSON
ajlm-2895	1	26	nazi boni university	ORG
ajlm-2895	1	27	burkina faso	ORG
ajlm-2895	1	28	institute of health sciences	ORG
ajlm-2895	1	29	nazi boni university	ORG
ajlm-2895	1	30	burkina faso department	ORG
ajlm-2895	1	31	sourô sanou university teaching hospital	ORG
ajlm-2895	1	32	burkina	GPE
ajlm-2895	1	33	hema department	ORG
ajlm-2895	2	1	burkina	GPE
ajlm-2895	2	2	faso	GPE
ajlm-2895	2	3	augustin konkobo	PERSON
ajlm-2895	2	4	nazi boni university	ORG
ajlm-2895	2	5	burkina faso centre muraz	ORG
ajlm-2895	2	6	burkina	GPE
ajlm-2895	2	7	hervé kafando	PERSON
ajlm-2895	2	8	nazi boni university	ORG
ajlm-2895	2	9	burkina	GPE
ajlm-2895	2	10	faso adama ouattara	GPE
ajlm-2895	2	11	institute of health sciences	ORG
ajlm-2895	2	12	nazi boni university	ORG
ajlm-2895	2	13	burkina faso division	ORG
ajlm-2895	2	14	sourô sanou university teaching hospital	ORG
ajlm-2895	2	15	burkina	GPE
ajlm-2895	2	16	faso	GPE
ajlm-2895	2	17	poda	GPE
ajlm-2895	2	18	nazi boni university	ORG
ajlm-2895	2	19	burkina faso	ORG
ajlm-2895	2	20	institute of health sciences	ORG
ajlm-2895	2	21	nazi boni university	ORG
ajlm-2895	2	22	burkina faso department	ORG
ajlm-2895	3	1	burkina	GPE
ajlm-2895	3	2	faso	GPE
ajlm-2895	3	3	sylvain godreuil joint research	ORG
ajlm-2895	3	4	research institute for development	ORG
ajlm-2895	3	5	montpellier	ORG
ajlm-2895	3	6	france	GPE
ajlm-2895	3	7	sourô sanou university teaching hospital	ORG
ajlm-2895	3	8	burkina faso burkina	ORG
ajlm-2895	3	9	burkina faso	ORG
ajlm-2895	3	10	nazi boni university	ORG
ajlm-2895	3	11	burkina faso	ORG
ajlm-2895	3	12	institute of health sciences	ORG
ajlm-2895	3	13	nazi boni university	ORG
ajlm-2895	3	14	burkina faso centre muraz	ORG
ajlm-2895	3	15	burkina	GPE
ajlm-2895	3	16	faso	GPE
ajlm-2895	3	17	kaboré	PERSON
ajlm-2895	3	18	gonfouli mj	PERSON
ajlm-2895	4	1	the sourô sanou university teaching hospital	ORG
ajlm-2895	4	2	burkina faso	ORG
ajlm-2895	5	1	afr j	PERSON
ajlm-2895	6	1	2024;14(1	CARDINAL
ajlm-2895	6	2	the sourô sanou university teaching hospital	ORG
ajlm-2895	6	3	burkina faso	ORG
ajlm-2895	6	4	d. kaboré	PERSON
ajlm-2895	6	5	mélissa j. gonfouli	PERSON
ajlm-2895	6	6	abdourahmane sow	DATE
ajlm-2895	6	7	fernand michodigni	ORG
ajlm-2895	6	8	andré nagalo	PERSON
ajlm-2895	6	9	jacques zoungrana	PERSON
ajlm-2895	6	10	arsène hema	PERSON
ajlm-2895	6	11	augustin konkobo	PERSON
ajlm-2895	6	12	hervé kafando	PERSON
ajlm-2895	6	13	adama ouattara	GPE
ajlm-2895	6	14	poda	GPE
ajlm-2895	6	15	sylvain godreuil	PERSON
ajlm-2895	6	16	abdoul	GPE
ajlm-2895	6	17	07 june 2025	DATE
ajlm-2895	6	18	14 oct. 2025	DATE
ajlm-2895	6	19	18	CARDINAL
ajlm-2895	6	20	dec.	DATE
ajlm-2895	7	1	2025	CARDINAL
ajlm-2895	10	1	4.0	CARDINAL
ajlm-2895	10	2	4.0	CARDINAL
ajlm-2895	10	3	https://creativecommons.org/licenses/by/4.0/	WORK_OF_ART
ajlm-2895	11	1	burkina	GPE
ajlm-2895	11	2	faso	GPE
ajlm-2895	14	1	the sourô sanou university teaching hospital laboratory	ORG
ajlm-2895	14	2	burkina faso	ORG
ajlm-2895	16	1	carbapenem	PERSON
ajlm-2895	16	2	31	CARDINAL
ajlm-2895	17	1	kirby-bauer	ORG
ajlm-2895	17	2	the european committee	ORG
ajlm-2895	17	3	2021	CARDINAL
ajlm-2895	18	1	117	CARDINAL
ajlm-2895	18	2	93	CARDINAL
ajlm-2895	18	3	15	CARDINAL
ajlm-2895	18	4	9	CARDINAL
ajlm-2895	19	1	58%	PERCENT
ajlm-2895	19	2	crs	ORG
ajlm-2895	19	3	34%	PERCENT
ajlm-2895	19	4	40/117	CARDINAL
ajlm-2895	19	5	8%	PERCENT
ajlm-2895	19	6	9/117	CARDINAL
ajlm-2895	20	1	95.5%	PERCENT
ajlm-2895	20	2	43/45	CARDINAL
ajlm-2895	20	3	72.5%	PERCENT
ajlm-2895	20	4	29/40	CARDINAL
ajlm-2895	20	5	crs	ORG
ajlm-2895	20	6	10/15	CARDINAL
ajlm-2895	20	7	89%	PERCENT
ajlm-2895	20	8	8/9	CARDINAL
ajlm-2895	21	1	carbapenem	PERSON
ajlm-2895	22	1	first	ORDINAL
ajlm-2895	22	2	burkina	GPE
ajlm-2895	22	3	faso	GPE
ajlm-2895	23	1	burkina	GPE
ajlm-2895	23	2	burkina	GPE
ajlm-2895	23	3	faso	GPE
ajlm-2895	24	1	acinetobacter baumannii	PERSON
ajlm-2895	24	2	burkina faso	ORG
ajlm-2895	25	1	the 21st century	DATE
ajlm-2895	25	2	2019	DATE
ajlm-2895	25	3	approximately 4.95 million	CARDINAL
ajlm-2895	25	4	1.27 million	CARDINAL
ajlm-2895	26	1	africa	LOC
ajlm-2895	26	2	27.3	CARDINAL
ajlm-2895	26	3	100 000	QUANTITY
ajlm-2895	26	4	carbapenem	PERSON
ajlm-2895	27	1	first	ORDINAL
ajlm-2895	27	2	carbapenem	PERSON
ajlm-2895	28	1	the last two decades	DATE
ajlm-2895	28	2	one	CARDINAL
ajlm-2895	28	3	9-tertbutyl-glycylamido	QUANTITY
ajlm-2895	28	4	30s	DATE
ajlm-2895	30	1	9th	ORDINAL
ajlm-2895	30	2	gram	CARDINAL
ajlm-2895	30	3	gram	CARDINAL
ajlm-2895	30	4	2005	DATE
ajlm-2895	30	5	the us food and drug administration	ORG
ajlm-2895	30	6	the european commission	ORG
ajlm-2895	30	7	the european union	ORG
ajlm-2895	30	8	24 april 2006.14	DATE
ajlm-2895	30	9	burkina faso	ORG
ajlm-2895	30	10	burkina	GPE
ajlm-2895	30	11	faso	GPE
ajlm-2895	33	1	helsinki	ORG
ajlm-2895	36	1	the burkina faso ministry of health	ORG
ajlm-2895	37	1	burkina	GPE
ajlm-2895	37	2	faso	GPE
ajlm-2895	38	1	carbapenem	PERSON
ajlm-2895	38	2	31	CARDINAL
ajlm-2895	38	3	2022	CARDINAL
ajlm-2895	39	1	sourô sanou university teaching hospital	ORG
ajlm-2895	40	1	the burkina faso national reference laboratory	ORG
ajlm-2895	42	1	crs	ORG
ajlm-2895	42	2	providencia	ORG
ajlm-2895	42	3	morganella morganii	ORG
ajlm-2895	45	1	gram	CARDINAL
ajlm-2895	47	1	20e	CARDINAL
ajlm-2895	47	2	20	CARDINAL
ajlm-2895	47	3	biomérieux	ORG
ajlm-2895	47	4	france	GPE
ajlm-2895	47	5	gram	CARDINAL
ajlm-2895	48	1	1	CARDINAL
ajlm-2895	48	2	3%	PERCENT
ajlm-2895	49	1	coagulase	NORP
ajlm-2895	49	2	10 seconds	TIME
ajlm-2895	50	1	gram	CARDINAL
ajlm-2895	50	2	s. aureus	PERSON
ajlm-2895	51	1	kb	ORG
ajlm-2895	51	2	mueller-hinton	ORG
ajlm-2895	51	3	biomaxima	GPE
ajlm-2895	51	4	lublin	GPE
ajlm-2895	51	5	poland	GPE
ajlm-2895	52	1	5 ml	QUANTITY
ajlm-2895	53	1	0.5	CARDINAL
ajlm-2895	53	2	mcfarland	GPE
ajlm-2895	53	3	mha	ORG
ajlm-2895	54	1	37 °	QUANTITY
ajlm-2895	54	2	overnight	TIME
ajlm-2895	55	1	15	CARDINAL
ajlm-2895	55	2	2021.18	CARDINAL
ajlm-2895	56	1	30	CARDINAL
ajlm-2895	56	2	third	ORDINAL
ajlm-2895	56	3	ceftriaxone	GPE
ajlm-2895	56	4	30	CARDINAL
ajlm-2895	57	1	30	CARDINAL
ajlm-2895	57	2	30 mm	QUANTITY
ajlm-2895	57	3	20	CARDINAL
ajlm-2895	58	1	third	ORDINAL
ajlm-2895	58	2	30	CARDINAL
ajlm-2895	58	3	20	CARDINAL
ajlm-2895	58	4	image.18 carbapenem-resistant	PERSON
ajlm-2895	58	5	25 mm	QUANTITY
ajlm-2895	58	6	10	CARDINAL
ajlm-2895	59	1	a. baumannii	PERSON
ajlm-2895	59	2	10	CARDINAL
ajlm-2895	59	3	21 mm	QUANTITY
ajlm-2895	59	4	meropenem 10	FAC
ajlm-2895	59	5	15 mm	QUANTITY
ajlm-2895	59	6	30	CARDINAL
ajlm-2895	59	7	22 mm	QUANTITY
ajlm-2895	59	8	15	CARDINAL
ajlm-2895	59	9	2021	CARDINAL
ajlm-2895	59	10	18 mm	QUANTITY
ajlm-2895	60	1	19 mm	QUANTITY
ajlm-2895	60	2	fda	ORG
ajlm-2895	61	1	19 mm	QUANTITY
ajlm-2895	61	2	fda	ORG
ajlm-2895	61	3	19 mm	QUANTITY
ajlm-2895	61	4	19 mm	QUANTITY
ajlm-2895	61	5	fda	ORG
ajlm-2895	61	6	15 mm	QUANTITY
ajlm-2895	61	7	18 mm	QUANTITY
ajlm-2895	61	8	≤ 14 mm	QUANTITY
ajlm-2895	61	9	25922	DATE
ajlm-2895	61	10	s. aureus	PERSON
ajlm-2895	61	11	25929	DATE
ajlm-2895	61	12	700603	DATE
ajlm-2895	61	13	microsoft	ORG
ajlm-2895	61	14	2016	CARDINAL
ajlm-2895	62	1	7	CARDINAL
ajlm-2895	63	1	95%	PERCENT
ajlm-2895	64	1	pearson chi-square	PERSON
ajlm-2895	64	2	fisher	ORG
ajlm-2895	65	1	5%	PERCENT
ajlm-2895	66	1	986	CARDINAL
ajlm-2895	66	2	01 june 2022 to	DATE
ajlm-2895	66	3	31	CARDINAL
ajlm-2895	67	1	44.52%	PERCENT
ajlm-2895	68	1	439	CARDINAL
ajlm-2895	68	2	117	CARDINAL
ajlm-2895	68	3	26.65%	PERCENT
ajlm-2895	68	4	117	CARDINAL
ajlm-2895	68	5	1	CARDINAL
ajlm-2895	69	1	1	CARDINAL
ajlm-2895	69	2	117	CARDINAL
ajlm-2895	69	3	burkina faso	ORG
ajlm-2895	69	4	01 june 2022	DATE
ajlm-2895	69	5	31	CARDINAL
ajlm-2895	69	6	2022	CARDINAL
ajlm-2895	70	1	117	CARDINAL
ajlm-2895	70	2	53.8%	PERCENT
ajlm-2895	71	1	117	CARDINAL
ajlm-2895	71	2	41.27	CARDINAL
ajlm-2895	71	3	17.9 years	DATE
ajlm-2895	71	4	1 month to 85 years	DATE
ajlm-2895	72	1	40–50 years	DATE
ajlm-2895	72	2	17.9%	PERCENT
ajlm-2895	72	3	20–30 years	DATE
ajlm-2895	72	4	14.5%	PERCENT
ajlm-2895	73	1	80%	PERCENT
ajlm-2895	73	2	the sourô sanou university teaching hospital	ORG
ajlm-2895	73	3	20%	PERCENT
ajlm-2895	74	1	14.5%	PERCENT
ajlm-2895	74	2	12%	PERCENT
ajlm-2895	75	1	117	CARDINAL
ajlm-2895	75	2	117 mdr	QUANTITY
ajlm-2895	75	3	e. coli	PERSON
ajlm-2895	75	4	0.018	CARDINAL
ajlm-2895	75	5	53%	PERCENT
ajlm-2895	75	6	62/117	CARDINAL
ajlm-2895	75	7	k. pneumoniae	PERSON
ajlm-2895	75	8	17%	PERCENT
ajlm-2895	76	1	2	CARDINAL
ajlm-2895	76	2	13%	PERCENT
ajlm-2895	76	3	9%	PERCENT
ajlm-2895	76	4	k. oxytoca	PERSON
ajlm-2895	76	5	5%	PERCENT
ajlm-2895	77	1	2	CARDINAL
ajlm-2895	77	2	burkina faso	ORG
ajlm-2895	77	3	01 june 2022	DATE
ajlm-2895	77	4	31	CARDINAL
ajlm-2895	77	5	117	CARDINAL
ajlm-2895	78	1	117	CARDINAL
ajlm-2895	78	2	58%	PERCENT
ajlm-2895	78	3	e. coli	PERSON
ajlm-2895	78	4	72.58%	PERCENT
ajlm-2895	78	5	k. pneumoniae	PERSON
ajlm-2895	78	6	67%	PERCENT
ajlm-2895	79	1	crs	ORG
ajlm-2895	79	2	37%	PERCENT
ajlm-2895	79	3	0.001	CARDINAL
ajlm-2895	79	4	crs	ORG
ajlm-2895	80	1	a. baumannii	PERSON
ajlm-2895	81	1	nine	CARDINAL
ajlm-2895	81	2	1	CARDINAL
ajlm-2895	81	3	1	CARDINAL
ajlm-2895	81	4	sourô sanou university teaching hospital	ORG
ajlm-2895	81	5	burkina faso	ORG
ajlm-2895	81	6	01 june 2022	DATE
ajlm-2895	81	7	31	CARDINAL
ajlm-2895	81	8	117	CARDINAL
ajlm-2895	82	1	nine	CARDINAL
ajlm-2895	82	2	6 (	PERCENT
ajlm-2895	82	3	66.67%	PERCENT
ajlm-2895	82	4	e. coli	PERSON
ajlm-2895	82	5	2	CARDINAL
ajlm-2895	82	6	4	CARDINAL
ajlm-2895	82	7	3 (	PERCENT
ajlm-2895	82	8	33.33%	PERCENT
ajlm-2895	83	1	k. pneumoniae	PERSON
ajlm-2895	83	2	1	CARDINAL
ajlm-2895	83	3	2	CARDINAL
ajlm-2895	84	1	k. oxytoca	PERSON
ajlm-2895	84	2	raoultella terrigena	PERSON
ajlm-2895	85	1	a. baumannii	PERSON
ajlm-2895	85	2	66.67%	PERCENT
ajlm-2895	85	3	10/15	CARDINAL
ajlm-2895	86	1	0.32	CARDINAL
ajlm-2895	86	2	2	CARDINAL
ajlm-2895	86	3	2	CARDINAL
ajlm-2895	86	4	sourô sanou university teaching hospital	ORG
ajlm-2895	86	5	burkina faso	ORG
ajlm-2895	86	6	01 june 2022	DATE
ajlm-2895	86	7	31	CARDINAL
ajlm-2895	86	8	2022	CARDINAL
ajlm-2895	87	1	117	CARDINAL
ajlm-2895	87	2	95.33%	PERCENT
ajlm-2895	87	3	0.002	CARDINAL
ajlm-2895	88	1	68	CARDINAL
ajlm-2895	88	2	65	CARDINAL
ajlm-2895	88	3	95.59%	PERCENT
ajlm-2895	89	1	40	CARDINAL
ajlm-2895	89	2	crs	ORG
ajlm-2895	89	3	29	CARDINAL
ajlm-2895	89	4	72.50%	PERCENT
ajlm-2895	90	1	nine	CARDINAL
ajlm-2895	91	1	3	CARDINAL
ajlm-2895	91	2	3	CARDINAL
ajlm-2895	91	3	sourô sanou university teaching hospital	ORG
ajlm-2895	91	4	burkina faso	ORG
ajlm-2895	91	5	01 june 2022	DATE
ajlm-2895	91	6	31	CARDINAL
ajlm-2895	92	1	two	CARDINAL
ajlm-2895	93	1	45	CARDINAL
ajlm-2895	93	2	17	CARDINAL
ajlm-2895	93	3	96%	PERCENT
ajlm-2895	93	4	43/45	CARDINAL
ajlm-2895	93	5	76%	PERCENT
ajlm-2895	93	6	13/17	CARDINAL
ajlm-2895	93	7	0.04	CARDINAL
ajlm-2895	93	8	3	CARDINAL
ajlm-2895	94	1	3	CARDINAL
ajlm-2895	94	2	62	CARDINAL
ajlm-2895	94	3	0.04	CARDINAL
ajlm-2895	94	4	27	CARDINAL
ajlm-2895	94	5	0.1	CARDINAL
ajlm-2895	94	6	sourô sanou university teaching hospital	ORG
ajlm-2895	94	7	burkina faso	ORG
ajlm-2895	94	8	01 june 2022	DATE
ajlm-2895	94	9	31	CARDINAL
ajlm-2895	96	1	27	CARDINAL
ajlm-2895	96	2	7	CARDINAL
ajlm-2895	96	3	20	CARDINAL
ajlm-2895	97	1	14	CARDINAL
ajlm-2895	97	2	k. pneumoniae	PERSON
ajlm-2895	97	3	6 k. oxytoca	QUANTITY
ajlm-2895	98	1	71%	PERCENT
ajlm-2895	98	2	5/7	CARDINAL
ajlm-2895	98	3	0.1	CARDINAL
ajlm-2895	98	4	3	CARDINAL
ajlm-2895	99	1	crs	PRODUCT
ajlm-2895	100	1	96%	PERCENT
ajlm-2895	100	2	65/68	CARDINAL
ajlm-2895	101	1	more than 99%	PERCENT
ajlm-2895	101	2	1936	DATE
ajlm-2895	101	3	e. coli isolates.20	ORG
ajlm-2895	101	4	2012	DATE
ajlm-2895	101	5	2016	DATE
ajlm-2895	102	1	98.4%	PERCENT
ajlm-2895	102	2	90.4%	PERCENT
ajlm-2895	103	1	spain	GPE
ajlm-2895	103	2	bazi	NORP
ajlm-2895	104	1	76%).23	CARDINAL
ajlm-2895	104	2	burkina	GPE
ajlm-2895	104	3	faso	GPE
ajlm-2895	104	4	gram	CARDINAL
ajlm-2895	104	5	72.5%	PERCENT
ajlm-2895	104	6	29/40	CARDINAL
ajlm-2895	105	1	bazi	NORP
ajlm-2895	106	1	morocco,23	CARDINAL
ajlm-2895	106	2	morocco	GPE
ajlm-2895	106	3	57%	PERCENT
ajlm-2895	106	4	gram	CARDINAL
ajlm-2895	106	5	67%	PERCENT
ajlm-2895	107	1	burkina faso	ORG
ajlm-2895	108	1	gram	CARDINAL
ajlm-2895	108	2	13/17	CARDINAL
ajlm-2895	108	3	76%	PERCENT
ajlm-2895	108	4	k. pneumoniae	PERSON
ajlm-2895	108	5	5/7	CARDINAL
ajlm-2895	108	6	71%	PERCENT
ajlm-2895	108	7	fatima et al	PERSON
ajlm-2895	109	1	pakistan	GPE
ajlm-2895	109	2	97%	PERCENT
ajlm-2895	109	3	34/35	CARDINAL
ajlm-2895	109	4	86.3%	PERCENT
ajlm-2895	109	5	wang et al.	PERSON
ajlm-2895	110	1	china	GPE
ajlm-2895	110	2	97.73%	PERCENT
ajlm-2895	110	3	64.86%	PERCENT
ajlm-2895	110	4	china	GPE
ajlm-2895	110	5	crkp	GPE
ajlm-2895	110	6	66%	PERCENT
ajlm-2895	111	1	bazi	NORP
ajlm-2895	112	1	66%	PERCENT
ajlm-2895	112	2	navon-venezia	NORP
ajlm-2895	112	3	leavitt	PERSON
ajlm-2895	112	4	66%	PERCENT
ajlm-2895	112	5	nahid et al	PERSON
ajlm-2895	113	1	south africa	GPE
ajlm-2895	114	1	75.8%	PERCENT
ajlm-2895	114	2	mha	ORG
ajlm-2895	114	3	mha	ORG
ajlm-2895	114	4	oxoid versus mha	ORG
ajlm-2895	114	5	91%	PERCENT
ajlm-2895	114	6	87.3%	PERCENT
ajlm-2895	114	7	kb	ORG
ajlm-2895	114	8	kb	ORG
ajlm-2895	114	9	a. baumannii	PERSON
ajlm-2895	115	1	biomérieux	ORG
ajlm-2895	116	1	one	CARDINAL
ajlm-2895	116	2	1/9	CARDINAL
ajlm-2895	116	3	11%	PERCENT
ajlm-2895	117	1	che hamzah et al	FAC
ajlm-2895	118	1	terengganu	GPE
ajlm-2895	118	2	malaysia	GPE
ajlm-2895	118	3	94%	PERCENT
ajlm-2895	118	4	85/90	CARDINAL
ajlm-2895	118	5	mrsa.46	ORG
ajlm-2895	118	6	89%	PERCENT
ajlm-2895	118	7	99.9%	PERCENT
ajlm-2895	118	8	7098	CARDINAL
ajlm-2895	118	9	khalili et al	PERSON
ajlm-2895	118	10	100%	PERCENT
ajlm-2895	118	11	99	CARDINAL
ajlm-2895	118	12	kb	ORG
ajlm-2895	118	13	tehran	GPE
ajlm-2895	118	14	iran.49	GPE
ajlm-2895	118	15	30	CARDINAL
ajlm-2895	118	16	kb	ORG
ajlm-2895	119	1	s. aureus worldwide,47,49,50	ORG
ajlm-2895	120	1	first	ORDINAL
ajlm-2895	120	2	burkina	GPE
ajlm-2895	120	3	faso	GPE
ajlm-2895	123	1	sourô sanou university teaching hospital	ORG
ajlm-2895	123	2	carbapenem	PERSON
ajlm-2895	125	1	crs	ORG
ajlm-2895	127	1	burkina faso	ORG
ajlm-2895	128	1	crs	PRODUCT
ajlm-2895	129	1	burkina	GPE
ajlm-2895	129	2	faso	GPE
ajlm-2895	130	1	fda	ORG
ajlm-2895	130	2	burkina	GPE
ajlm-2895	131	1	madam salimata	PERSON
ajlm-2895	131	2	adama kaboré	PERSON
ajlm-2895	133	1	d. kaboré	PERSON
ajlm-2895	133	2	abdoul	GPE
ajlm-2895	134	1	abdourahmane sow	DATE
ajlm-2895	134	2	sylvain godreuil:	PERSON
ajlm-2895	135	1	mélissa j. gonfouli	PERSON
ajlm-2895	135	2	d. kaboré	PERSON
ajlm-2895	136	1	d. kaboré	PERSON
ajlm-2895	136	2	mélissa j. gonfouli	PERSON
ajlm-2895	136	3	abdourahmane sow	DATE
ajlm-2895	136	4	adama ouattara	ORG
ajlm-2895	136	5	andré nagalo	PERSON
ajlm-2895	136	6	hervé kafando	PERSON
ajlm-2895	136	7	augustin konkobo	PERSON
ajlm-2895	136	8	jacques zoungrana	PERSON
ajlm-2895	136	9	arsène hema	PERSON
ajlm-2895	136	10	poda	GPE
ajlm-2895	136	11	abdoul	GPE
ajlm-2895	136	12	fernand	ORG
ajlm-2895	140	1	d. kaboré	PERSON
ajlm-2895	147	1	2015;40(4):277–283	CARDINAL
ajlm-2895	148	1	murray cj	PERSON
ajlm-2895	148	2	ikuta ks	PERSON
ajlm-2895	148	3	2019	DATE
ajlm-2895	149	1	lancet 2022;399(10325):629–655	PERSON
ajlm-2895	150	1	https://doi.org/10.1016/s0140-6736(21)02724-0	GPE
ajlm-2895	150	2	pendleton jn	GPE
ajlm-2895	150	3	gorman sp	PERSON
ajlm-2895	150	4	gilmore	PERSON
ajlm-2895	153	1	2013;11(3):297–308	CARDINAL
ajlm-2895	153	2	indrawattana n. mechanisms	PERSON
ajlm-2895	154	1	2016;2016(1):2475067	CARDINAL
ajlm-2895	155	1	https://doi.org/10.1155/2016/2475067	ORG
ajlm-2895	155	2	ga	ORG
ajlm-2895	156	1	j antimicrob	PERSON
ajlm-2895	157	1	2005;56(3):470–480	CARDINAL
ajlm-2895	159	1	alder j	PERSON
ajlm-2895	159	2	thorne gm	PERSON
ajlm-2895	159	3	daptomycin	PERSON
ajlm-2895	160	1	j antimicrob	PERSON
ajlm-2895	161	1	2005;55(3):283–288	CARDINAL
ajlm-2895	162	1	https://doi.org/10.1093/jac/dkh546 dutronc h	ORG
ajlm-2895	162	2	bocquentin f	PRODUCT
ajlm-2895	162	3	galpérine t	PERSON
ajlm-2895	162	4	dupon m. le linézolide	PERSON
ajlm-2895	162	5	de la famille des oxazolidinones	ORG
ajlm-2895	164	1	2005;35(9):427–434	CARDINAL
ajlm-2895	164	2	saeed si	PERSON
ajlm-2895	164	3	hakizimana jn	PERSON
ajlm-2895	165	1	africa	LOC
ajlm-2895	166	1	biosci	GPE
ajlm-2895	167	1	petersen	PERSON
ajlm-2895	168	1	bioorg med chem	ORG
ajlm-2895	169	1	1999;9(10):1459–1462	DATE
ajlm-2895	170	1	bauer g.	PERSON
ajlm-2895	170	2	16s	CARDINAL
ajlm-2895	171	1	j antimicrob	PERSON
ajlm-2895	172	1	2004;53(4):592–599	CARDINAL
ajlm-2895	175	1	curr pharm des.	ORG
ajlm-2895	178	1	rybak mj	PERSON
ajlm-2895	178	2	tigecycline	PERSON
ajlm-2895	179	1	first	ORDINAL
ajlm-2895	182	1	kasbekar n.	PERSON
ajlm-2895	183	1	j health syst pharm	ORG
ajlm-2895	184	1	2006;63(13):1235–1243	CARDINAL
ajlm-2895	187	1	european	NORP
ajlm-2895	187	2	ema	ORG
ajlm-2895	188	1	2024 aug 02	DATE
ajlm-2895	189	1	https://www.ema.europa.eu/en/medicines/human/epar/tygacil zhang y	QUANTITY
ajlm-2895	189	2	zhou l	PERSON
ajlm-2895	191	1	shanghai	GPE
ajlm-2895	191	2	china	GPE
ajlm-2895	193	1	2004;50(4):267–281	CARDINAL
ajlm-2895	194	1	aryal s. api	ORG
ajlm-2895	194	2	20e	CARDINAL
ajlm-2895	196	1	2019	DATE
ajlm-2895	196	2	2024	CARDINAL
ajlm-2895	196	3	aug 04	DATE
ajlm-2895	197	1	https://microbiologyinfo.com/api-20e-test/ bauer	PERSON
ajlm-2895	197	2	kirby wmm	PERSON
ajlm-2895	197	3	sherris jc	PERSON
ajlm-2895	197	4	turck m. antibiotic	PERSON
ajlm-2895	198	1	j clin	PERSON
ajlm-2895	199	1	1966;45(4_ts):493–496	ORDINAL
ajlm-2895	199	2	https://doi.org/10.1093/ajcp/45.4_ts.493 société française de microbiologie	ORG
ajlm-2895	201	1	2024	CARDINAL
ajlm-2895	201	2	aug 04	DATE
ajlm-2895	203	1	acta clin croat	PERSON
ajlm-2895	204	1	2022;61(1):46–51	DATE
ajlm-2895	204	2	kelesidis t	GPE
ajlm-2895	206	1	j antimicrob	PERSON
ajlm-2895	207	1	2008;62(5):895–904.	TIME
ajlm-2895	208	1	https://doi.org/10.1093/jac/dkn311 zhang j	PERSON
ajlm-2895	209	1	ann palliat med	PERSON
ajlm-2895	211	1	garcía	GPE
ajlm-2895	213	1	antimicrob	PERSON
ajlm-2895	214	1	2006;50(8):2695–2699	CARDINAL
ajlm-2895	215	1	bazi ke	PERSON
ajlm-2895	215	2	miloudi	ORG
ajlm-2895	216	1	7-year	DATE
ajlm-2895	219	1	2022;11(1):79–83	CARDINAL
ajlm-2895	220	1	f. tigecycline	PERSON
ajlm-2895	221	1	j chemother	PERSON
ajlm-2895	223	1	ku y-h	PERSON
ajlm-2895	223	2	chuang y-c	PERSON
ajlm-2895	223	3	yu w-l.	PERSON
ajlm-2895	225	1	2008;41(4):332–336	CARDINAL
ajlm-2895	226	1	miltgen g	PERSON
ajlm-2895	226	2	martak d	GPE
ajlm-2895	226	3	french	NORP
ajlm-2895	226	4	indian	NORP
ajlm-2895	227	1	antimicrob	PERSON
ajlm-2895	228	1	2020;9(1):36	CARDINAL
ajlm-2895	229	1	reygaert wc	PERSON
ajlm-2895	231	1	2018;4(3):482–501	CARDINAL
ajlm-2895	232	1	yildiz s	ORG
ajlm-2895	235	1	2014;31(9):2387–2401	CARDINAL
ajlm-2895	236	1	https://doi.org/10.1093/molbev/msu191 giammanco	PERSON
ajlm-2895	237	1	fasciana t	LOC
ajlm-2895	237	2	gram	CARDINAL
ajlm-2895	237	3	between 2004 and 2014	DATE
ajlm-2895	239	1	2017;2(1):e00310	CARDINAL
ajlm-2895	240	1	https://doi.org/10.1128/msphere.00310-16 fatima m	PERSON
ajlm-2895	240	2	gohar h.	PERSON
ajlm-2895	240	3	carbapenem	PERSON
ajlm-2895	241	1	pak	ORG
ajlm-2895	242	1	2021;10(3):17–23	CARDINAL
ajlm-2895	242	2	mohanty s	PERSON
ajlm-2895	242	3	mahapatra a.	PERSON
ajlm-2895	243	1	ann med surg	PERSON
ajlm-2895	245	1	wang j	PERSON
ajlm-2895	245	2	liu j	PERSON
ajlm-2895	245	3	lin	PERSON
ajlm-2895	248	1	2025;15:1600746	CARDINAL
ajlm-2895	249	1	https://doi.org/10.3389/fcimb.2025.1600746	NORP
ajlm-2895	249	2	huang l-y	PERSON
ajlm-2895	249	3	chen h	PERSON
ajlm-2895	250	1	antimicrob	PERSON
ajlm-2895	251	1	2017	CARDINAL
ajlm-2895	253	1	https://doi.org/10.1128/aac.00391-17 chen h	PERSON
ajlm-2895	253	2	jiang y	PERSON
ajlm-2895	253	3	li m	PERSON
ajlm-2895	255	1	2021;12:674502	TIME
ajlm-2895	256	1	abdel hameed mr	PERSON
ajlm-2895	256	2	el-mokhtar	PERSON
ajlm-2895	259	1	2018;67(7):972–975	DATE
ajlm-2895	260	1	https://doi.org/10.1099/jmm.0.000770 navon-venezia s	PERSON
ajlm-2895	260	2	leavitt	PERSON
ajlm-2895	261	1	j antimicrob	PERSON
ajlm-2895	262	1	2007;59(4):772–774	CARDINAL
ajlm-2895	263	1	https://doi.org/10.1093/jac/dkm018 ahmed nh	PERSON
ajlm-2895	263	2	baba k	PERSON
ajlm-2895	264	1	carbapenem	PERSON
ajlm-2895	264	2	pretoria	GPE
ajlm-2895	264	3	south africa	GPE
ajlm-2895	265	1	bmc res	ORG
ajlm-2895	266	1	2012;5(1):215	CARDINAL
ajlm-2895	267	1	guo y	PERSON
ajlm-2895	267	2	li m	PERSON
ajlm-2895	267	3	vitek 2	ORG
ajlm-2895	267	4	kirby	PERSON
ajlm-2895	267	5	bauer	PERSON
ajlm-2895	267	6	k. pneumoniae	PERSON
ajlm-2895	267	7	a. baumannii	PERSON
ajlm-2895	267	8	china	GPE
ajlm-2895	268	1	j clin microbiol	PERSON
ajlm-2895	270	1	https://doi.org/10.1007/s10096-020-04123-z zarkotou o	GPE
ajlm-2895	270	2	pournaras s	ORG
ajlm-2895	270	3	gram	CARDINAL
ajlm-2895	271	1	j clin microbiol	PERSON
ajlm-2895	272	1	2020;50(11):3747–3750	CARDINAL
ajlm-2895	273	1	yu r	PERSON
ajlm-2895	273	2	lü x.	PERSON
ajlm-2895	275	1	j antimicrob	PERSON
ajlm-2895	276	1	2014;69(6):1710–1711	CARDINAL
ajlm-2895	277	1	fernández-mazarrasa	PERSON
ajlm-2895	277	2	mazarrasa o	ORG
ajlm-2895	277	3	calvo j	PERSON
ajlm-2895	277	4	arco	ORG
ajlm-2895	277	5	del	GPE
ajlm-2895	277	6	manganese	NORP
ajlm-2895	277	7	mueller-hinton	ORG
ajlm-2895	278	1	j clin microbiol	PERSON
ajlm-2895	279	1	2009;47(3):827–829	CARDINAL
ajlm-2895	280	1	jones rn	PERSON
ajlm-2895	280	2	ferraro mj	PERSON
ajlm-2895	280	3	swenson jm	PERSON
ajlm-2895	280	4	sader hs	PERSON
ajlm-2895	281	1	j clin microbiol	PERSON
ajlm-2895	282	1	2007;45(1):227–230	CARDINAL
ajlm-2895	283	1	https://doi.org/10.1128/jcm.01588-06	GPE
ajlm-2895	283	2	rodríguez f	ORG
ajlm-2895	283	3	johnson b	PERSON
ajlm-2895	284	1	j antimicrob	PERSON
ajlm-2895	285	1	2009;64(1):69–72	CARDINAL
ajlm-2895	286	1	mushtaq s	PERSON
ajlm-2895	286	2	james d	PERSON
ajlm-2895	286	3	uk	GPE
ajlm-2895	286	4	j antimicrob	PERSON
ajlm-2895	288	1	https://doi.org/10.1093/jac/dkq370 lall s	PERSON
ajlm-2895	288	2	biswas s	ORG
ajlm-2895	288	3	khattry n. comparative	FAC
ajlm-2895	289	1	j. 2024;18(4):17–21	PERSON
ajlm-2895	290	1	che hamzah am	PERSON
ajlm-2895	290	2	yeo cc	PERSON
ajlm-2895	290	3	terengganu	GPE
ajlm-2895	290	4	malaysia	GPE
ajlm-2895	293	1	huband md	GPE
ajlm-2895	293	2	streit jm	PERSON
ajlm-2895	293	3	flamm rk	PERSON
ajlm-2895	293	4	sader hs	PERSON
ajlm-2895	293	5	north america	LOC
ajlm-2895	293	6	europe	LOC
ajlm-2895	293	7	latin america	LOC
ajlm-2895	293	8	asia-pacific	LOC
ajlm-2895	293	9	2016	CARDINAL
ajlm-2895	294	1	j antimicrob	PERSON
ajlm-2895	295	1	2018;51(6):848–853	CARDINAL
ajlm-2895	296	1	yang	PERSON
ajlm-2895	296	2	xu y-c	PERSON
ajlm-2895	296	3	kiratisin p	PERSON
ajlm-2895	296	4	dowzicky mj	PERSON
ajlm-2895	296	5	gram	CARDINAL
ajlm-2895	296	6	gram	CARDINAL
ajlm-2895	296	7	asia-pacific	LOC
ajlm-2895	296	8	2015	CARDINAL
ajlm-2895	296	9	previous years	DATE
ajlm-2895	298	1	2017;89(4):314–323	CARDINAL
ajlm-2895	298	2	khalili	PERSON
ajlm-2895	298	3	rasoolinejad m.	PERSON
ajlm-2895	299	1	iran	GPE
ajlm-2895	300	1	2010;9(1):61–65	CARDINAL
ajlm-2895	301	1	putnam	ORG
ajlm-2895	301	2	sader hs	PERSON
ajlm-2895	301	3	farrell	PERSON
ajlm-2895	301	4	jones rn.	PERSON
ajlm-2895	301	5	united states medical centers	ORG
ajlm-2895	301	6	2004 through 2008	DATE
ajlm-2895	302	1	j chemother	PERSON
ajlm-2895	304	1	prasad p	ORG
ajlm-2895	304	2	sun j	PERSON
ajlm-2895	304	3	natanson c.	PERSON
ajlm-2895	305	1	clin infect dis	ORG